Source: Aotearoa Clinical Trials
Auckland, New Zealand – February 10, 2025 – Aotearoa Clinical Trials is pleased to announce the opening of a new, third site in Botany, East Auckland, expanding its reach and further cementing its commitment to the local community. This new standalone site will allow the clinical trial organisation to provide enhanced access to a diverse range of participants, while strategically supporting the Counties Manukau region’s rapidly growing population.
Why are clinical trials important to this community?
“Research is incredibly important as it provides pathways to addressing current health challenges. In Māoridom, research is akin to the role of a tohunga (expert or healer)-it represents foresight in the face of illness. As Māori, we all possess the taonga (treasure) of rangatiratanga (sovereignty and leadership); we have this foresight. I believe that my living data today is far more valuable to helping prevent disease than data collected after my death. You can’t solve a problem by only knowing that I died in my 50s from diabetes. It could have been prevented if I had been tested earlier. I believe that if I give the system my blood today, it will help them develop interventions, because prevention is better than cure”. Kaumaatua Robert Clark.
With significant growth in housing developments, infrastructure projects, and shopping centres, Botany is one of Auckland’s most thriving and dynamic areas. It is home to a vibrant, ethnically diverse community, making it an ideal location for Aotearoa Clinical Trials to continue its mission of bringing essential clinical research closer to the people it serves.
“We are excited to announce the expansion of our clinical trials into the Botany region,” said Ed Watson, CEO of Aotearoa Clinical Trials. “As we build our presence in East Auckland, we are not only responding to a clear need in the community but also aligning with our broader strategy to reach more individuals from diverse backgrounds, especially within Counties Manukau, one of New Zealand’s most multicultural regions. This site will play a crucial role in improving access to medical research for communities that need it the most.”
The Botany site will be staffed by a dedicated team of clinical investigators, who bring extensive experience in conducting high-quality clinical trials across various therapeutic areas. By offering increased access to a wide range of participants, the Botany location will help accelerate advancements in medical research while improving healthcare outcomes for local communities.
Aotearoa Clinical Trials’ expansion to Botany is part of a larger strategy to build deeper connections within the community through decentralised clinical trials (DCTs) and thereby providing access to participants in their communities. The organisation has plans to also collaborate with Pukekohe Hospital, extending its reach even further across the Counties Manukau area.
The addition of the Botany site brings a new level of convenience and access to East Auckland, which, in turn, will further strengthen the network of clinical trials available to the surrounding regions.
About Aotearoa Clinical Trials
Aotearoa Clinical Trials is a leading provider of clinical trial services in New Zealand, offering world-class research across many therapeutic areas from Phase I to Phase IV. With a focus on providing greater access to diverse populations, Aotearoa Clinical Trials partners with healthcare providers, sponsors, and local communities to deliver vital research that improves patient outcomes.
